1. Home
  2. SRRK vs EPRT Comparison

SRRK vs EPRT Comparison

Compare SRRK & EPRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scholar Rock Holding Corporation

SRRK

Scholar Rock Holding Corporation

HOLD

Current Price

$56.97

Market Cap

6.8B

Sector

Health Care

ML Signal

HOLD

Logo Essential Properties Realty Trust Inc.

EPRT

Essential Properties Realty Trust Inc.

HOLD

Current Price

$31.21

Market Cap

6.6B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRRK
EPRT
Founded
2012
2016
Country
United States
United States
Employees
289
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
6.8B
6.6B
IPO Year
2018
2018

Fundamental Metrics

Financial Performance
Metric
SRRK
EPRT
Price
$56.97
$31.21
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
12
Target Price
$56.17
$36.79
AVG Volume (30 Days)
1.5M
1.7M
Earning Date
05-07-2026
04-22-2026
Dividend Yield
N/A
3.98%
EPS Growth
N/A
11.30
EPS
N/A
0.28
Revenue
N/A
$561,219,000.00
Revenue This Year
N/A
$17.12
Revenue Next Year
$534.24
$16.27
P/E Ratio
N/A
$111.43
Revenue Growth
N/A
24.82
52 Week Low
$27.07
$28.95
52 Week High
$58.12
$34.73

Technical Indicators

Market Signals
Indicator
SRRK
EPRT
Relative Strength Index (RSI) 67.12 56.72
Support Level $41.38 $29.27
Resistance Level N/A $31.43
Average True Range (ATR) 2.45 0.55
MACD 0.52 0.15
Stochastic Oscillator 85.32 77.93

Price Performance

Historical Comparison
SRRK
EPRT

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.

About EPRT Essential Properties Realty Trust Inc.

Essential Properties Realty Trust Inc is a real estate investment trust. It is an internally managed real estate company acquires, owns and manages single-tenant properties that are net leased on a long-term basis to middle-market companies operating service-oriented or experience-based businesses. The Company generally invests in and leases freestanding, single-tenant commercial real estate facilities where a tenant services its customers and conducts activities that are essential to the generation of the tenant's sales and profits.

Share on Social Networks: